<SEC-DOCUMENT>0001213900-20-033693.txt : 20201028
<SEC-HEADER>0001213900-20-033693.hdr.sgml : 20201028
<ACCEPTANCE-DATETIME>20201028161727
ACCESSION NUMBER:		0001213900-20-033693
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20201028
DATE AS OF CHANGE:		20201028
EFFECTIVENESS DATE:		20201028

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Actinium Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001388320
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				880378336
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36374
		FILM NUMBER:		201268859

	BUSINESS ADDRESS:	
		STREET 1:		275 MADISON AVENUE, 7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		646-677-3875

	MAIL ADDRESS:	
		STREET 1:		275 MADISON AVENUE, 7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cactus Ventures, Inc.
		DATE OF NAME CHANGE:	20070130
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>ea129030-defa14a_actiniumph.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SCHEDULE 14A INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Proxy Statement Pursuant to Section 14(a)
of</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Filed by the Registrant&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Filed by a Party other than the Registrant&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 24px"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Preliminary Proxy Statement</FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Definitive Proxy Statement</FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Definitive Additional Materials</FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Soliciting Material Pursuant to &sect;240.14a-12</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Actinium Pharmaceuticals, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Name of Registrant as Specified In Its Charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>N/A&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Payment of Filing Fee (Check the appropriate box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9746;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">No fee required.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Title of each class of securities to which
        transaction applies:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Aggregate number of securities to which transaction
        applies:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Per unit price or other underlying value of
        transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how
        it was determined):</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Proposed maximum aggregate value of transaction:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">5.</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Total fee paid:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Fee paid previously with preliminary materials:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&#9744;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amount previously paid:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Form, Schedule or Registration Statement No.:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Filing Party:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Date Filed:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pursuant
to Section&nbsp;13 or 15(d) of the</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Securities
Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Date
of Report (Date of earliest event reported): October 28, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ACTINIUM
PHARMACEUTICALS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(Exact
name of registrant as specified in its charter)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>001-36374</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>74-2963609</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(State or other
    jurisdiction<BR>
    of incorporation)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(Commission File
    Number)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(IRS Employer<BR>
    Identification No.)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>275
Madison Avenue, 7<SUP>th</SUP> Floor, New York, NY 10016</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(Address
of Principal Executive Offices)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Registrant&rsquo;s
telephone number: (646) 677-3870</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(Former
name or former address, if changed since last report)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (<U>see</U>&nbsp;General Instruction A.2. below):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title
    of each class</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Trading
    Symbol(s)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name
    of each exchange on which registered</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Common Stock,
    par value $0.001 per share</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ATNM</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>NYSE American</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: right; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Emerging
growth company&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item
7.01 Regulation FD Disclosure.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
October 28, 2020 , Actinium Pharmaceuticals, Inc. (the &ldquo;Company&rdquo;) issued a letter to shareholders, which is attached
hereto as Exhibit 99.1. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit
99.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including
Exhibit 99.1, shall not be deemed &ldquo;filed&rdquo; for the purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the &ldquo;Exchange Act&rdquo;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated
by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set
forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form
8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits
hereto, is material or that the dissemination of such information is required by Regulation FD.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item
9.01 Financial Statements and Exhibits.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)
Exhibits</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
    Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 91%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Description</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_001"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2020 Shareholder Letter, dated October 28, 2020 (furnished herewith pursuant to Item 7.01).</FONT></A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Actinium Pharmaceuticals,
    Inc.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date: &nbsp;October 28, 2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
        Sandesh Seth</I></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name: Sandesh Seth</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title: Chairman and Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><A NAME="a_001"></A>&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">October 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Actinium Shareholder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2020 thus far, we have made steady progress
with our Iomab-B SIERRA pivotal trial, which is in its final quartile of enrollment, and our Actimab-A combination trials in the
Relapsed and Refractory Acute Myeloid Leukemia (R/R AML) setting. We are on track and look forward to data updates related to this
progress by year-end; specifically, data from the first 75% of patients from the SIERRA trial, the Ad-Hoc interim analysis, and
POC data from our Actimab-A + CLAG-M combination trial. In addition, we have several other milestones across our platform that
will be reached in 4Q:2020 and 2021, setting the stage for a potentially transformational future for your company. We approach
these milestones with momentum across our clinical pipeline, enhanced R&amp;D capabilities, a strong balance sheet and highly motivated
colleagues. We are excited for Actinium&rsquo;s future, grateful for your support and look forward to creating value for all stakeholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Attractive Multi-Product, Multi-Indication
Opportunity in R/R AML Emerges in 2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The progress made this year with Iomab-B
and the Actimab-A therapeutic combination trials is exciting and potentially transformational. Taken together these programs can
address the still unmet needs of a large segment of patients with R/R AML and potentially change the way the disease is treated.
Despite 9 approved therapies for AML, a majority of patients relapse or become refractory at which point treatment options are
limited. Bone Marrow Transplant (BMT) remains the only curative treatment option but R/R AML patients typically cannot receive
one as they are unable to withstand the highly toxic chemotherapy conditioning agents currently being used. As depicted in the
graphic below, the ongoing pivotal Phase 3 SIERRA trial with Iomab-B is the backbone for our R/R AML strategy; enabling elderly,
unfit patients to access a BMT with the potential for improved survival. Our Actimab-A combination trials with CLAG-M and venetoclax
could be used either as therapeutics or a bridge to transplant in the fit and unfit patient segments. We eagerly await the data
events for Iomab-B and the proof of concept data for both Actimab-A combination trials by year-end and in 2021, respectively. Together
these results could set the stage for a much larger and attractive opportunity in R/R AML than either drug candidate alone.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><I>Upcoming Data Could Set Stage for
Expanded Market Opportunity in R/R AML</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex99-1_002.jpg" ALT=""></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The R/R AML patient population is largely
treated in approximately 75-100 tertiary care hospitals, which also conduct the majority of BMT procedures. Leveraging relationships
established with the leading AML treatment centers in our clinical trials and our supply chain capabilities, we believe that Iomab-B
and Actimab-A could be successfully commercialized into the tertiary care setting and envision building Actinium into a specialty
oncology company focused on addressing the R/R AML patient population with multiple products. Our programs are on the cusp of producing
data that can help us realize this vision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2020 &ndash; Accomplishments Across
All Major Pipeline Initiatives </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we hear of COVID-19 <I>ad nauseum</I>,
I am proud to report that Actinium was able to accomplish many of its clinical goals despite clinical sites being severely hampered
for several months. Our SIERRA trial was able to maintain enrollment because the trial investigators needed to keep treating very
sick R/R AML patients and recognized the demonstrated benefit of Iomab-B from the 50 percent interim analysis. Throughout this
period, dedicated teams at Actinium and our clinical sites were able to ensure that our supply chain capabilities were fully operational.
Highlighted below are some of the achievements we have made in 2020 and outlook into our major programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Targeted Conditioning Pipeline &ndash;
Value Creating Data Events Within Reach</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Iomab-B Program for BMT - Pivotal Phase
3 SIERRA Trial</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We note that, despite the late trial stage,
investigator interest driven by data updates published at the 50 percent mark has led to several additional sites joining or expected
to join the study. This data reported at the Transplantation &amp; Cellular Therapy Conference showed that 100% of patients receiving
Iomab-B underwent a BMT and engrafted, the first sign of a successful BMT outcome. Only 18% of control arm patients successfully
received a BMT. Additionally, the difference in number of patients potentially evaluable for the primary endpoint, measured by
100-day non-relapse transplant related mortality, has remained consistent at roughly 6x greater for the study arm at the 25% and
50% enrollment updates. With the trial in its final quartile of enrollment, we look forward to data updates from the 75 percent
enrollment mark and the interim ad-hoc analysis by year-end. The strong investigator interest in Iomab-B is a barometer for the
unmet need and we are hopeful that Iomab-B will be able to provide these patients improved access to a BMT and better outcomes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Iomab-ACT Program for CAR-T &ndash;
Proof of Concept Trial with MSK</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are collaborating with Memorial Sloan
Kettering Cancer Center (MSK) via an approach validating NIH STTR fast track grant to explore the benefit of using Iomab-ACT, a
low dose version of the ARC used in the Iomab-B program, to condition patients before they receive CAR-T therapy. MSK is a leader
in the field of cellular therapy and this trial is unique as it will be the first time an ARC has been used for conditioning for
any cellular therapy. The CAR-T construct, 19-28z, used in this trial, has proven efficacy in various blood cancers but is not
truly viable due to relatively high rates of cytokine release syndrome and neurotoxicity. Iomab-ACT can potentially address these
issues by selectively targeting and depleting immune cells implicated in these CAR-T toxicities and creating a better environment
for the CAR-T cells to expand and persist in order to attack the patient&rsquo;s cancer and potentially have lower side effects
and higher and more durable responses. We look forward to proof of concept data from this trial in 2021. There is an attractive
and potentially large opportunity for the Iomab-ACT program to become the universal conditioning regimen for CAR-T based therapies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Other Conditioning Programs &ndash;
Actimab-MDS and Iomab-ACT for Gene Therapy</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have completed our interactions with
FDA and have a clear pathway to a pivotal trial after a short dose confirming Phase 1 study (which we believe will likely be 4<I>u</I>Ci/kg
body weight) for the Actimab-MDS targeted conditioning study in high-risk patients with MDS or myelodysplastic syndrome. The start
of the gene therapy trial in HIV related lymphoma has been delayed as the University of California Davis was severely impacted
due to COVID-19 and cohort expansion in the trial which uses chemotherapy conditioning, highlighting the need improved conditioning
regimens. We will update on these programs as they move ahead in 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>CD33 Program Revitalization Via Therapeutic
Combination Trials Data </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our CD33 program is showing compelling
promise and could become an important driver of value. Recall, through the Phase 2 trial, we demonstrated that single-agent Actimab-A
was extremely potent (ORR of 69%) and had no extramedullary toxicity outside of myelosuppression. We are parlaying this profile
via a therapeutic combination strategy with established agents in R/R AML. As very few patients are cured with the 9 approved drugs,
R/R AML patients account for almost 70% of the AML population. Each of our Actimab-A combination trials adds low, sometimes sub-therapeutic
doses of Actimab-A, to established doses of drugs or drug cocktails and delivers internalized radiation to a highly radiation sensitive
liquid cancer. There is also a mechanistic synergy or potentiating effect possible from adding Actimab-A in the two combination
trials with CLAG-M and venetoclax. Actimab-A, in addition to its single agent activity can damage certain proteins like Mcl-1 and
act in concert with DNA damage response inhibitor drugs and yield extremely high patient response rates without compromising their
safety.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Supporting our approach are data from the
Actimab-A + CLAG-M trial which showed a very high remission rate of 86%, 60% higher than CLAG-M alone. This second dose cohort
combined a sub-therapeutic dose of Actimab-A with a standard CLAG-M regimen. Further, the minimal residual disease or MRD negative
rate was an impressive 71%, which bodes well for durability of response. Venetoclax combinations are arguably the most widely prescribed
regimen but most patients ultimately fail, and our trial is attracting significant investigator interest which has led to site
expansion. We are excited as we believe these data events can demonstrate the immense value creating potential of our CD33 program,
which has been largely overshadowed by Iomab-B and is deserving of further attention. We look forward to presenting updated POC
data from our CLAG-M combination and first human data from the venetoclax combination Phase 1 trial by year-end.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Why Bolster R&amp;D Capabilities at
Actinium? </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Actinium the company, was formed two decades
ago to harness the power of radioisotopes, in particular Actinium-225 or Ac-225, to treat and potentially even cure cancer. The
idea was far ahead of its time and the company certainly had its share of vicissitudes&hellip;we are the sixth management team.
We restarted R&amp;D three years ago, within a few months of our tenure, and have revitalized the aging patent portfolio, informed
CD45 and CD33 program expansion via our research and entered into a research partnership with a global biopharma company. We now
execute in a highly collaborative manner navigating complex scientific considerations, informed by commercial sensitivities, our
clinical know-how and supply chain expertise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While no one has cured cancer, not even
with a radiotherapeutic since Actinium was formed, there have been certain high-profile successes with radiopharmaceuticals that
have created tremendous value for shareholders. This success has attracted new entrants and significant investments. Given a fortified
balance sheet and potential for significant value creating clinical milestones by year-end that could enable us to build a specialty
oncology company, we have begun stage 2 of our R&amp;D plan. We have elected to develop internal laboratory capabilities to be
able to execute our plans more efficiently than using outside vendors. We believe that this internal R&amp;D capability is essential
to attract collaborators, accelerate planned clinical programs and strengthen our competitive position as a leader in developing
Ac-225 based therapeutics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are proud of the progress we have made
in 2020 in the face of tough operating conditions and are excited for year-end clinical milestones that can set the stage for a
potentially transformative 2021. Our strong balance sheet, enhanced team and capabilities, position your company well for value
creation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On behalf of our entire company and the
Board of Directors, I thank you for your commitment to Actinium Pharmaceuticals and supporting our mission to develop medicines
in areas where our product candidates can materially improve patient lives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>/s/ Sandesh Seth</U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sandesh Seth</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chairman and Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Key Achievements in 2020</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Key Upcoming Milestones</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 4%"><IMG SRC="ex99-1_004.jpg" ALT=""></TD>
    <TD STYLE="width: 42%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Iomab-B mid-point analysis of SIERRA</FONT></TD>
    <TD STYLE="vertical-align: top; width: 4%">&nbsp;</TD>
    <TD STYLE="width: 38%">&#9679;<FONT STYLE="font: 10pt Times New Roman, Times, Serif">Iomab-B SIERRA 75% patient data </FONT></TD>
    <TD STYLE="width: 12%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4Q:2020</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><IMG SRC="ex99-1_004.jpg" ALT=""></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Exercised ad hoc analysis for SIERRA</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&#9679;<FONT STYLE="font: 10pt Times New Roman, Times, Serif">Iomab-B SIERRA Ad Hoc Analysis </FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4Q:2020</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><IMG SRC="ex99-1_004.jpg" ALT=""></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Raised ~$60M in 1H:2020</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&#9679;<FONT STYLE="font: 10pt Times New Roman, Times, Serif">Actimab-A CLAG-M POC</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4Q:2020</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><IMG SRC="ex99-1_004.jpg" ALT=""></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Completed Phase 1 Actimab-A CLAG-M</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&#9679;<FONT STYLE="font: 10pt Times New Roman, Times, Serif">Actimab-A Venetoclax 1<SUP>st</SUP> human data</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4Q:2020</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><IMG SRC="ex99-1_004.jpg" ALT=""></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Initiated Actimab-A Venetoclax combo</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&#9679;<FONT STYLE="font: 10pt Times New Roman, Times, Serif">Actimab-A Venetoclax POC</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2021</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><IMG SRC="ex99-1_004.jpg" ALT=""></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Launched research facility </FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&#9679;<FONT STYLE="font: 10pt Times New Roman, Times, Serif">Iomab-ACT CD19 CAR-T POC</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2021</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><IMG SRC="ex99-1_004.jpg" ALT=""></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Iomab-ACT CAR-T Collaboration</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&#9679;<FONT STYLE="font: 10pt Times New Roman, Times, Serif">Actimab-A Gene Therapy update</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2021</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">4<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !# 1<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBFDGG
M Z'T[8SZ]?\ ZP[TFTE=_P!?\/L@'4PLJG'N <=N.I]!_+.?4UQGC3QWH?@;
M2WU+6+I$.&^SVP9?.N'"DJJ+G(!(^9OX1D]!7\I?[9'_  4__P""A-C_ ,%$
M+#X#?!/P/KY^&M[JWP=TWX>:!I'AHW^B^/-#\37&GCXC:WXDUL:9/=/.)[O5
M=+@GM]5TN+P=!H,&H+%)+<3SWOUW#7!.;\3^UJT)X7+L!1I5ZM7,LSK+#86V
M&IJI4AAY25ZU3DNUR>XG%\]2*/G,VXFR[*JKPC<\9F#INK' 83WZ[AM%U$K\
MB<FDD[MW7NG];TE]9QD*]U C ,2K3Q*0JC+,V6^ZH!9CS@9)XS2Q7MK<"-[>
MY@G21%D1H)8Y4DCD7>DD;(Q#HZ\HXRK+E@2",_A-_P %'?V4OVTOBQ^R-\1M
M _9_U^ZC^),NJ^$]630AK[:9?>+O"FC>(+;4?$OA"'4?,1()-;L(E$D<\L-G
MJ4=M)I=ZT5M>RL?/_P#@FS^SK^W3\"OV7M5NOCY=ZRWB6Z\<>+O&N@^"K;4S
MJ-]X4\+7&GV$P\-V,:2&WM%OM8L=4U.ST>T:33]-EU5HH-IEE1?H8\ Y!4PD
MZM/CS)'BHXJ&%CA)0E'VCG3<W4A-UN>4%-*FYJ#BN9/GO[IX3XOSF%'ZQ4X0
MS-4^9-4U*+K.ES<KJ<OLW!1BO>M*<96W1_1$&7GG&>>?<>_],BG5_+;_ ,$O
M_P#@N%\9/VJ?VCM1^#/Q;^&]GIGA6?POXUUBYO[#2+[3M7^%NN^%==MK+3O#
MFN7EU>W#:Y%J.GW3:=J4NI66F:M;^)K-GM(#I\LMI:?T[-XBT9-#F\23ZI86
MF@VNGW&JWFLWMU!:Z=8Z;:0/<W=_?7<[QV]G:6EO&\]S<7$B0P0QO)*ZHK,/
MEN)>$\YX4Q5+#9G1IRAB*=&MA<5A9NOA<12KPC4I.G44$_:<LX*5&4?:J35E
M.+C)_393GV79O"?U:KR5J,8RQ&%K.$:]!27Q3BG;D337M%[JY7=JQ8UK6-)T
M#2M0US7-0M=*T?2;*?4=2U.^GCMK.QLK:-I;BYN9Y65(H8HU9V9B.!QD\5^
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M-';6\TS@!$AD9SC]AJ^%>64\!EV,7'_#&)JXW"X+$K+\+B,/7QT*N+H8>O\
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M:_\ M7_"::3'93ZC+?>'+VWCDT_5(8K&TN+N86UY+)#;QB22-1+%N_/'Q5\
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M+9>B_(I?J_SD%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
/%%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $+ FX# 2(  A$! Q$!_\0
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M=-!TS0-+\6I806]_#\)/#VJBX7PF_A;P7HEHEG-KZW^IW8!_1G1110 4444
M%%%% !1110 4444 %%%% '':O\1/A_H'C#PC\/==\<^#]%\?>/X-?NO G@C5
MO$NC:=XN\:VWA6SAU#Q/<>$_#=Y>PZQXBA\.6%Q!>Z[+I%G>)I%I-%<W[6\,
MBN4\*_$7X?\ CJ]\7:;X)\<^#_&&H_#_ ,2W/@SQW8>%_$NC:_>>"O&%G;6U
M[=^%/%EKI5[=S>'?$EK9WMG=7.AZNEGJ<%M=6TTMJL<\;-^!/_!4_P")/P\_
M9T_X*X?\$3_VEOCOXKT'X5? 3PA9_M^_#WQ7\9O&UPFC?#WP=XO^(OP-\,VG
M@C1?%7BV[1=(\,2>++JPO;72;C5[NRM;J2SO"9UAL[J6'\C/ O[2'Q:T[PM^
MT3\8/V-?CYJ?PH\&?MV?\'0W@OX)^#/V@_!GA[PIXITGXB?!'XC?#R'PCXPU
MSP-;^.]"UGPOXOT!]<TI9](U>WM)].O=>T)(EO98(-0MI #^UKXG_%KX5_!'
MP=J/Q$^,WQ*\ _"7P!I$MK!JOC?XE^,/#_@;PEIL]],MM907WB+Q/J&F:1:S
M7EPZP6L4]XDEQ,RQ0J[D+5?P3\9?A!\2M(N?$'PZ^*OPX\>Z#9^)O^$*N];\
M&>-_#/BC2;7QEY-A<_\ ")7&HZ)J=]9P^)OL^J:9/_84DRZIY.HV,GV79=P&
M3^&W]JM/VAOVF/ WP^_9H^/W[8WQ<^(FF?LT?\'+OPG_ &(/!WQ#UCPQ\%Y/
M&/BOP%XT\(:+XE\(>,OB-IDWPYD\#>,OB+\)[^]\11>#GN_"T'A'4H_$.JVG
MBOPEKEE!H]KI5SXY:[K>N>-O@9JOC?\ :?U7]GGX=?!K_@YR_:@^ LGC+P;H
MGP/^%OA#PUHOAGX8V9\%^/?%]T/A_9>%+CX@:!#H>I>&=-\1>*K>\6]TSQQX
MACU:+4+JUT"?1P#^\^B@=/Y?3M10 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5X=X/\ VG?V;?B%\2O$OP9\ _M!?!+QO\7O!HN6\7?"
MSPC\5/ WB/XB^%ULI!#>GQ!X*T?7;SQ)HXLIF6&\.H:;;_9)66*X\MV53PG[
M=FG_ !FU7]B?]KK2_P!G1M47X^:C^S5\;['X,'0Y&AUT_$Z[^&_B2#P2N@S(
M0T.NMXA>P71I5(:+4S:NK*5!'\R'_!.SQK_P1%O_  K_ ,$<?AS\*_@U#XP_
MX*$>#3H*:CIWP&\.3>'?VD/@K\;=#^&5]9_M%^,_VT=2T;5?!_B]?ATOC8:]
M8>,[7XE3>)=(U:XU"RDTGPUJ>@6\J6X!_8UD>H_/_/J/SHR/4>O7MZU_&+^R
M#_P4E_:T^('Q=_8C^(FJ_ML:K\5/VI/VGOVX/BA^SW^UQ_P29D\'?#;3](_9
M0^ _AO6_BIIVJ>,=-\.:5X4L_C3\.]2^!GAWP7X,\8ZK\0O'?B6\TWQ]%XF^
MQW8N%%TU[A_L'?ML?\%"KFT_X(]_M'>/?VSOB+^T%9_MW_$K]N3X+?$+]GSQ
M;X,^$>F_#V32O@5IGQHOOA9>>%M2\(^"-!\81^/KGQ!X&TF/6?$E[KUT-3BO
M[/0X=/L].L94U, _M7R/6BOXDOV?_P#@IO\ M*0?LH>+?VF_#/\ P4VU/]IW
M]NKQK^Q/^UC\:O'W_!-R_P#@-X.\6:5\!OBA\+]52/3]3T>S^&_AG1O%7[/F
MF? RWDFM[[P/\;]0U^7XX"$PZ0[WXCD3Q[1O^"HO[>>B_L#_ /!0SQWX#_;6
MD^*__"K/@%^Q)\5?!'QDUSQ_^S!\8_BO\'?CG\9OV@OA_P"#_B#X8GN/@+X-
MM?AG8_#+QOX3U35KC1/AIX\BO_B-\/VT_4=$U,6<EXMV0#^\*_U'3]+L[G4=
M3OK/3M/LH7N+R_O[F&SL[2WC&9)[FZN'C@@A0<O+*Z(HY9@*N9&,YXZY[8]:
M_A&_X*J^(/VI=$^#'_!6O]DGXO?MQ_&GXO\ P\_9B\>?\$E/CMH7Q!\5>'OA
M)X7\56EE^TA\6=2TGXI^%?$]UX*\#Z%H,'PH\+ZOI6@_$;PEI"Z9;?\ "-ZK
MX9T.RU35M8T9M9AUG[1T#]I_]IB'X^_\%:OC1/\ \%./C/J?[(/_  3.^"_P
M'UGX9:3\/_A'\"/CDGQ?G^,7[#&G^(1\9M?DLM$\+6OCJVLO%LMO\6M%\.:)
MXD\*>!=<\5W=S?ZIK6A^!K>6Q4 _K>OKZRTRSNM1U*\M=/T^QMYKR^O[ZXAM
M+.SM+>-I;BZNKJX>."WMX(E:2:>9TBBC5G=E4$U85T=5=&5T=0R.K!E96 96
M5@2&5E(8$$@@@CBO\X/XT?MH?M)?M0?L1?\ !5#X.>*_VR?BY\4OA)\//@!^
MPC^TGX2U?Q'\3?V7?BM\0)'\;?M#>'O"?Q-T'Q/XP_9L\&6/@;0? US;:GI?
MBKQ%\++35?$^J_#+4_#FAZ)KWC.>*7Q3I>J_<_[3_P#P4U_;:\!_M<?$CX=_
M!S]M5)-(_9\TO]@G0_V/5\>?$W]EOP_\+_VZ/!7Q?\-^#K_Q_P#&3XGZ#J?@
MZX^*W[2-Q\;+_5-=\.:!XB_9.BT3PM\,M;LX+N6RTT1WEPH!_;/XV^(7@+X:
M:1;>(/B-XV\)> ="O-:T7PU::UXS\1Z/X7TFZ\1>)-0ATGP]H-MJ.MWEC:3Z
MSKNJ7-OINCZ9%,U[J=_/#:64$T\B1GE?BY\?/@7\ -)TO7OCO\:/A1\%=#UN
M_ETO1M9^+/Q$\(_#K2M7U.&V>]FT[3-1\7ZOH]I?WT5G%)=26EK-+.EO&\[1
MB-2P_AE_;T_:N^)/Q[\0_'C2/V@?VY;WPG\4/AE_P6V^!'P!\!?\$S[K2/A=
M8:58_L[?#GXS?#C5OAS\7+33IO"\?Q>OM1\0P3S>,YOC!;^)O^$&UVR\WPO]
MCD;5-,BM/V0_X.'/"?B[QU\4O^"/'A#X?_#_ .!WQ5\;^(/V\M3T_P -?#O]
MI2WOKOX&>+=3D^$'B=HM*^)5MIFA^)=0F\-R%5EF2TT'593>16>+.3' !_1/
M\-OBK\+_ (R^%+3QW\(/B/X#^*O@B_GN+6Q\8_#?Q?X?\<>%KRYM&5+NVM?$
M'AG4-4TF>XM794N8(KMI8'8+*J,0*M^+?B+\/O -SX1L_'7CKP=X+N_B!XKL
M/ G@.U\6>)M%\.W/C7QQJMM>7FE^#O"4&KWMG+XC\4ZE::=?W5AX?T=;S5KN
MWL;N:WM)([:9D_CV\4? ?]K3_@D;\))M<\7?&[X$?L2:/_P4R_X*8?#.S_:3
M^(7['W@DP?LU?L#_  0E^'/B'34_X56?BUX:_P"$:\$>)_BKX@T31O#_ (A^
M*WC'P=9^$/#5U<::(=*69;*>W3PE^VA\?_'>J?LF>#M0_: T_P#:R^#?PY_X
M.%O@[^S'\"OVP?%7P]^$NMZG^T-\#+_X$_$/Q5XACM?$6G>#4\&ZQXG^''C9
MI?! ^.'PCTWPO?:TD#6]AJD,QU%KL _L\R/6J=CJ.GZG%)/IM]9ZA!%=7=C+
M-8W,-W%%>Z?<RV5_9R20/(B75E>036EW;LPEMKF&6"9$EC=!_%E^QQ^UI_P4
M$\:6W_!+?XU>/OV^/B]XST?]NS]KW]M7]D#QU\++WP9\%-/\(>$? /@2Z^/&
MD> O&OA/4=,^'5MXCG^*/A76?!VFZ]I_B76=3O["YABT/P[=Z'-I&GZA%K_Z
M!?\ !NUXCUKP;_P1MU[6?!/Q6\1?M,?%?P'XR_:SU27X0^(-:\,:AK7PW^(^
MA_$7XC:GHGP;EM?#>F:?XBT2\^)%U;Z7\3;VU\9RZCXBN-7^*=_J6G7,/AR\
MT*PM #^E;(]1TSU[>OT]Z\M^%_QS^"GQOA\47'P8^+WPQ^+=OX(\17'A'QE/
M\,_'GA;QU#X3\5VD:377AKQ)+X7U35(]$UZWADCEGTC4FMK^*-T=X K G^.C
M]DK]N_\ :H^.WBG]COPGIW_!2KQG^T!\2OV^?@3^V/+^W5\!_"W@SX/Z9K?_
M  3=U?P9\+?$>M>#O'/P]T?0_ \?B3X&ZA\+_B!%9?#.+2OCI-XLTWXE:@T5
MW;V=WJ-YITL/W1_P1-^#/Q'\!_\ !N7!?_L_^)_$&N_''XT_LT?M">._A2MO
MH_@C0-5\+?%34/#WCGPSX%\-^%]3\)>'/#NH:O\ 9/&&B6>JZ3K7CG4?$OBB
M'6M7N8;C7_[)MM.TW3@#^A#PS^T]^S9XT^*6O? [P=^T'\$?%?QI\*B[;Q-\
M(O#?Q5\"ZY\3O#PT_P#Y"!UKP'IFNW7BG3/L&1]N^VZ7#]C+*+GRBRY]QR/4
M<=>>E?QE_P#!.+QC_P $4)OA'_P1Y^&VB?"&T\7_ /!2/PAXT\$P^(M"^"7A
M6_\ #_[6_P (_P!HW0_!GB&/]HWXB?M9W^FW_@_XA#X2Z;XOMO$;_$#3OB/?
M:[H>NZ?=:&=.\)ZYH&G&"P\._9H_X*V_M(_$K]NKX<V7@+]LSXN_%+X.?M$?
M#_\ X*33^(/"7QAD_96T#4?">M? /X6?$3QS\(+KP5^S;\*M*UOXJ?LMR^&=
M8\'P6&D6GQU^(GB'Q=\6=#L-0UZ7PQIUFUS*X!_=-D'H0:*_A2U7]L;_ (*,
M_"S]C[_@E/\ $/XO?M^?&/6O"W_!2J#Q'\1?C7\<H+S]E/\ 9ZN/@9%X!^"]
MKKWPM^!GP[^,/QC\(GX)> ;CXI:OJ-YK_C'Q)\2+*;7O'=_X$NM$\&G3Y]2U
M6WNOZB_^"1OQK^./[0W_  3V_9V^+?[17BOPC\0/BIXFT?Q;#JOQ&\#S:9-X
M>^(FB>'_ !_XI\.>#O&\;:)IND:%_:OB'PEI6C7OB-] TVT\/7/B%M4O?#\*
M:+<V H _2*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R==T#0O
M%&E7F@^)M%TGQ%H>H)''?Z-KNFV>KZ5?)%-'<1)>:=J$-Q9W*1W$,4\:S0N$
MFBCE4!T5AK44 8VM>'/#WB32WT/Q%H6C:_HLKVLDFCZUI=CJNER/8W$-W8N^
MGWT$]H[V=U;P7-JS0DV]Q!#-"4DC1EJ6?@WPAIWB;6/&FG^%/#=CXQ\0V=EI
M^O\ BRST+2[7Q-KEAIBA-.L=8UZ"U35-3L]/156RMKVZGAM% 6!(P *Z2B@
MHHHH **** "BBB@ HHHH **** "BBB@#F_%?@WPAX\T:X\.>./"OAOQGX>NW
MCDN]!\5Z'IGB+1;EX23"]QI>KVMY8S/$23&TD#%"25()JK!\/_ =MH_A_P .
MVW@GPC;^'_"5]9ZIX5T*#PWHT6C^&=3TYYI-/U'P_ID=DMEHM]8R7$\EG=Z;
M!;7%L\\SP2(TCENNHH Y%_A_X#DEDFD\$^$9)IO%%OXWFE?PWHS2R^-+2-8;
M7Q?)(UD6?Q1;0JL5OK[$ZM#&JI'=JH %/5?A?\,]=TR]T37/AWX%UG1M3\1'
MQAJ6D:MX2T#4=,U#Q:9%F/BF^L+S3YK6[\1F5$E.MW$4FIF1%<W6Y01W5% !
M1110 4444 %%%% !1110 4444 %%%% !1110 45\Z_M)?M4_!3]D_P &6OC;
MXT^*3H5EJM\^E^'-&TZQNM:\4>*M3BB^T3V/A[0;%'NKUK.W(N-0O93;:7IL
M#1R:A?6JSP>9Y?\ LQ?\%"?V7_VMM9OO"GPH\9W\/CS3=,DUN[\ >,M#OO"W
MBMM%BFCMY]5TZ"Z$VEZ]96LLT2WLF@:KJC6'FQ&^2V$D9;EEC<'#$QP<L5AX
MXJ<5*.'E5@JTHN]FJ;ES.]FTOB:3<8M)L^8K\:\'X7B/#\'XGBGA_#\5XNA'
M$X7ANMF^ I9UB*$U.5.I2RZ>(CB9JI"G4G2@HJK5IPE4I4*M.+F?;5%%%=1]
M.%%%9VK:G!HVF7VJW2R/;Z?;2W4RPA6E:.%2S"-69%+$ A0S*">I%.,7*48Q
M3E*4E&*6[E)I)+;5MI;K?<4I*,92DTHQ3E)O91BFVWY))M^AHUS&F>"/!FBZ
M]J_BK1_"/AC2?$^OKMUWQ'IF@:58:]K:^8DNW5]8M;2+4-27S8XY,7EQ,/,1
M'QN52/$M?_:G^&_AP,;^W\0N5!)%O964AR,Y7YM03D8Y';BO$/$/_!2/X#>&
M]YOM*\?R^7G=]FT;2'^[UQYFO1>_X"O<P_#'$.*M]6R?'5K[>SI1E?\ \K(\
MN>>Y/2O[3,<-"V_-.7Z4F?:5E\._A_IOBS5/'NG>!O!UAXZURS33];\:67AG
M1;7Q9K%A&8S'8ZIXC@L8]8U"SC,412VN[R:%3''M0;%P^S^'W@+3H?#UOI_@
MCPA8V_A*[O;_ ,*06?AK1K6'PS?:EY_]HWOAZ*"R1-%N[_[5<_;;G35MIKK[
M1/Y[R>;)N_/WP'_P54_9T^(GQ1\"_"70M"^)L7B7X@^);'PMHEQJ&@Z)!I<6
MHW_F>1)?W$7B2XN(;4>4WF/%:SR+QB)LU] :G^V=\%?#5WJ:^.+W7_ VBV^N
M>*]#T/Q/KFD"^T?Q6W@/Q+J/@KQMJFF6WA:[\1>(=&T3PSXQTUO#5[JOC70_
M"MG=ZEJ.AII$NI1ZU8/+RYIDN:Y+4HT<VP&)R^KB*+KT*>)A&$JM%3=-U(*-
M2I>'M$X7;3NK6.G!9A@<QA.I@<52Q4*4U3J2HR<E";CSJ+;C#5Q?-L].I[_H
MOP[^'_AK7O$7BGP[X&\':!XG\7RB;Q9XCT7PSHNE:]XHF#F03>(M7L;*#4-:
ME#LSB34KBY?>Q;.236;IOPA^$^BZ!JWA31_AA\/-)\+:_J']KZ[X:TWP5X:L
M- UK5?/ANO[3U;1K73(M.U+4/M-M;W'VV\MIKGSX(9O-\R)&7YUN/^"@W[(E
MFNC-??%N.P77[S4=-TEKWP9\0;;[7JNB6<5YX@TD++X45TU;PV;K3K'Q)ILB
MI>Z#K&KZ-HNJPVNJZM86<^1-_P %'/V1K73]8U*]^(FKV%OH^MQ>')!??#SX
MA6D]YK5S%/\ 8M.LH9O#".;R]U"SU+0X+2[%I=IK>E:CI]S!;O;EF\P[#ZWU
M7P!X$UU?$::YX*\):RGC#3[/2?%JZKX;T;45\4Z5IPE&GZ9XC6\LIAK>GV F
MF%G9:F+JVM1+*((T$C972/ /@7P_:ZE8Z#X+\):)8ZSI]AI.KV>D>'-'TVUU
M72]*TT:+IFFZE;V=G##?:?IVC@:386=TDMO9Z:!86\<=J/*KYN\(?MV_LQ>-
M]6\(^'M$^(%TWB+QOJ%EI.@:)/X1\8"ZEU&^U*PT86MW=6^AW.DV+6&LZOHF
MBZY-=:C':^'M:UW1='UV?3]2U*VM7D3]N']GF;6?&.EVWB+Q%=V?@'P]IGB'
MQ3XBL_ WB^ZT.R37O&D7@/PUI5B8-(?5]?U3Q/K<IGT >'=)U;3M0T6-]934
M5L'AEE /;].^#'P>TC2KG0])^%'PUTO1+S0KKPM=Z/IW@7PO9:5=>&;Z]EU*
M]\.7.GVVEQ6D^A7FHSS7]UI$L+:?<7LTMU+;O/(\AM?\*F^%?]H>$-6_X5G\
M/_[4^'UE#IG@+4O^$,\.?VAX(TVW3RX-/\(7G]F_:/#5E!'\D-IHTEE!&GRI
M&J\5\GWO_!2[]C&QU*[L9?B_;R6>GN;>^U^W\-^*I] AU&0VQL=)MK^/1F?5
M]5U:"]M+[2;/0K?5'OM-G_M*(_88;F>'L-"_;Q_9>\2>./#GP_TCX@WD^M^+
M]2TC1?#%U/X+\;V&@ZWK6OW6JV^BZ79Z]?\ AZVTP3:NFD7%YI-U<7$&F:M9
M3V$VF7]X;ZW1P#Z#U3X6?##6M?NO%>L_#?P'J_BF^M],M+WQ)J?@_P /7^OW
M=KHUY!J&CVUUK%WI\NHW%OI-_;6U[IL,MR\=A=V\%S:K%-$CKT>I^'O#VMW6
MCWVLZ#H^KWWAZ^_M7P_=ZGI=E?W6AZF8G@.I:/<74$TNF7Q@EDA-Y9/#<>3(
M\1DVN5.R> 3Z<^G2OP9_X+ _MG_M/?LW^-?A!X(^".KW/P^\->*/#6H^*-0\
M<6?AC3=>OO$GB:RUPZ?'X)LKC7=+U?2XTTRQBM-3OM*LK/\ MC55UNS02I:0
M,D_#F684<KPE7&XB-6=*ER*4:--U:DG4FJ<5&*:6LI*\I-12M=W<;_"^)'B!
MDOA?P?FG&O$&'S7%Y7E4\#2K8?)<!+,<PJU<QQU#+\-&CAXSI1477Q$/:5:U
M6E1I1Y>:?/5HPJ?NAKN@:#XJT?4/#WB?1-)\1^']6MVM-5T/7M-L]7T?4[5V
M#-;:AIFH0W%E>V[,JLT-S!)&6525RO&-9_#WP!IVD^&=!T_P/X/L-#\%WD&H
M^#M&L_#.BVND^$]0M1<"VOO#.G0626>@WEN+NZ$%UI<-K/"+FX$;J)I-WSS<
M?M)6WP2_9E^%/Q@_:J\KP-XI\0:1\+-%\;Z3I]O&'L?B%XWCTNTU6TAL)[F!
M;:VT.:?5?$'B*+[0YT/P_HFMW*F\&F;)L;4_^"@'[+FCZQ<Z3JGCG5[**#3[
M35(-9F\"^-QHFKV5[?:E907GA^[&@&7Q!I@CTF]U:?7='MKWP_:Z L.NW&K1
MZ5<073]D)<\8S2:4HQDE).,DI1C)*47K&24K2B]5)-/5,^RPF(CB\+A<7"%:
ME#%8;#XJ%+$4I4,13AB</0Q$*>(H3]^A7IQKQA7HS]^C6A5I3]ZG(^H+7X?>
M K&'0[>Q\$>$+.W\,ZG>:UX;@M?#6C6\/A[6-1:X?4-6T.*&R1-)U.^>\NVO
M+^P6WNKIKJX:>5S/*6L^&_!7@WP8NKKX/\)>&?"BZ_J]SK^NKX;T'2M"76]>
MO!&MYK>KC2[2U&I:O=+%$MSJ5YYUY.(XQ+,X1<?,4G[?/[)T0T8/\6+6676X
M[:6&'3O#/C'7/L"75Y>:>CZS<Z#X?U2QT>W6^T[4;=KV_NX;!CI]Y-%=2VT#
M3UAM_P %!/V?;+X@^)/A[X@?QUX:F\+^*/%OA#4?%NI>$+G4/ RZUX*UJ[\/
MZW!<>(?#-UX@&AXU:T6VM(_%%IH-S<+J&C7'V=+?6])EO*.@^KM(^'7P^\/Z
MWXC\2Z#X%\&Z)XC\8L7\7:_I'AC1--UOQ4Y+$OXCU6SL8;[7&)9B6U.>Z)+,
M<Y)K<T30M$\-:59:%X<T?2O#^B:;$8=.T;1-/M-*TJPA,CRF*RT^PA@M+6(R
MR22F."&-3([N1N9B?D/2/^"A?[(>O0Z1=:1\6&OK'6X89[+4X? OQ'_LB.&9
MF1Y-1U=O"(TS24LY8KJ#4FU2[M%TR>PU&"_-O+87:Q5X/^"B_P"QK/8Z)JB_
M&BQCTOQ%>W6EZ1J4_A/Q[#87.K:=;/>:SI#W<GA98+;5/#]K]EN/$-C<O#<:
M%!JFC3:HEK%K&G/<@'UC8>!_!>E>(M3\7:7X0\+Z;XLUJ+R-9\3V&@:39^(M
M6@W1OY.IZU;VD>I7\6^*)_+NKF5-T4;8RBD8MG\(_A1IVH7>K:?\,?AY8:KJ
M&L7_ (AO]3L_!?ANUU"]U_5+&?2]3UR[O8--2YN=8U'3+FYTZ_U.:1[V\L;B
M>TN)Y+>62-OGB+]OK]EN7Q!XE\.CXA7/VCPLNJS:A?)X5\57.F3V>@6L4_B#
M5-/N;/1[F2ZT/0;J>#1=5UXP1:-!XAGM]"2_EU*Y@MY(/#'[?W[,GCC0_%NM
M^"_&.I>)_P#A$?#,'C&72]/\-ZO;:EKOAN_\0V?A/1]2\/'5[?3--O$U?Q+J
M%CH\<-YJ6GW&DW-W!+XEBT.T<7- 'TUJ_P -/AQX@\)0> ->^'_@G6_ EK':
M0VO@K5_"FA:EX2MH; @V,4'AN\L)M&ACLB ;2..R5;8@&$)7665C9:99VFG:
M=9VNGZ?I]K;V-A864$5I965E:1)!:V=I:P)'!;6MM!''#;P0QI%#$B1QHJ*%
M'QI-^WY^SMHU]K&A^.-:USX>^*O#UW-IVN>&/$VDQWEYI5_:K$EW#?ZSX2O?
M$_A*QM8-0N;714U>^\16NC7NM7=MIMAJ%U<R;!T^D?MK_LZ^(O&VC_#CPYXR
MOM:\;ZYH-[XJL?#L/A;Q+IE^?#%EX;\2>*AKSC7]+T>(V%[I/AN2?3A#+-=7
MD6M>&[Z.V_LK6K74* /JZBO@#2?^"F/[*<[:)!XH\4>(/A]?ZY;B2'3O%7AN
M[N;K3[V37;70;;0];/A&3Q3!HWB&XFNFU Z)J4MM?V>D66J:EJ,-G;Z;>-%Z
M3)^W)^S/':>!M4;Q]='0?B-I?B75?"GB%?"'C(Z/=0^$/%-MX0\26^I2C0?M
M.@WFCZI<2W&HP:[::=]AT6PU+7+U[?3+*6Y !];45\5>.O\ @H+^RY\./$?B
M/PIXN\;:OINM>'->'A@VZ^#/%EU%KVO0SZI::G8>&KBWTF2+5X]%OM$U73]4
MU.-HM'CU'3[[3[74;J\LKR&#Z)^$GQC^&WQU\&V_Q!^%'BBU\8>#KO4-3TNV
MUNTM-3L89KW2+I[2]C6WU:RT^]\M9%$EO<&V%O>VLL%[9RSVEQ#-( >F4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '"I\2?
M![_$R?X0+JC'Q_;>!;7XDS:+]BO@B>#[W7[SPQ;:I_:)M_[-9Y-:L+NT^Q+=
M&]58O/:W$#)(W=5\2VW_ "D=UO\ [,E\+_\ J]O%]?;5 WT]$PHHHH$%%%%
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MSCJDFX34':5[Z7<5?F^%LZJ6:86HVI2E2TO>HDD]&[7CS)-;:[O8^K**\E\
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M@CQ9I?@?Q3^T!\/]*\3:VG@&?3; ZC<WL$]A\4XUD^'6LR:II]I=:1:>'_&
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ML-&M"IR*-**;BDXOZ!LXIX;6VBNKC[7=100QW-V(DMQ=3I$B37/V>,F.'SI
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M14(RFY1@HII**;=DD[)=%L0J<8-RC!1E*[E)12<F]6V[:M]1*<@RZ#U=1^;
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M]YAD5KU^$?\ P7F'Q);X#_"-/#\6KO\ "T_$:^D^*3Z>DKZ;'J$>E0+\//\
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M  =K  # &&!!&.QS3[AWDCM?-8NPB=@6 SM:9PO;D83"^@X&!@"M4]QQ($'
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ME1QE^WG_  33^"OP<^ WC3]I+]I.2.;1? NK:7\+%^!__"0$7VM^'?AO\6O
M>B?&"Y\,6TNUIM2UZ"YU[1O!DD]N&N;ZU\&K/(YCO;ISYA_P5*_X*&?$6RT?
MP[\)?A0LG@W0?B/H<^OZAXAN+='\23^'K&^M;9(;8N9;.QN+_4A-;S1M'>QP
M6-K.'5[JY@>TZN[U.\O(K>UDG9+"RM-&L+#2X#Y&EZ?8^'=$L_#6AVUEIT6V
MTMDTS0=/LM*@>*)9#:VR+*[N7=O%?VKO@5;?&GX/>%=3>W%MXO\ "VD>,8_
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M\=OI]M=7%Q#/9I/ MI=B2,&VFV8/C7X8>+]>\;:/XR\)?$J#PE>Z9X USP+
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M[CL_$-I EGKNG7%RBC[9;W]N(Y)98Y$CE$=W]H@8H0\3!W#>PTF._?IG_/\
M6MJ&(KX6K&MAJU6A5@[QJ4IRIR36VL9*\;[QES1DKJ46F[YU:5.M!TZM.%2$
MM)0J1C.+3OTDFK^:LT[-.Z1_,]\?/V6O'/PF^,'PU\6^+]'MWL='L_B7X?T3
MQ-9W%M<V6KVNH6NCMI\NU76YM)XT:]E2UN+>.6%[ZZV_("YP:_HZ^)OPM\(?
M%GPO>^%_%NFQ7<$\4PL=0"+_ &CHMY(BB/4=*N2OF6US$Z1LVQE2X13!.'B9
ME/\ /?XY\(:CX \8^)?!6K213:AX9UB[TJ>>$YANE@<&WNX\X(6ZMGAGV$9C
M,A0\J:_9N#\\H9K2QL9TX4<R=58O&^S@H4\5*=.AA8XJFDV^=PPU&G6C)Z3B
MI0?LY*,?S3,>'L-DF(Q6(P=*,*.:XQXNO)1BISQGU;"X:4JSC&+G)X?"X>,*
MDG*3IT8Q<KP2.4(!!!&0000>A!X(/UK[K^''Q*OO&?PHT?PWJ["[U3P1K)TX
MWS%VN9-#DL/^)"+C(Q)(BB]L#,K,6BT^V$BK(=S?"I_+Z^G>OK7X0^&!H/A@
M:U/]L74O%</F-:W)>"WM-,LKV5=/F6R9 TEQ>%'N8;Z4@"RG$=O&4E:5_:SR
MG0J86FZJ3JTZ\)X=VNU4Y9QFDTTU&5*4_:7O'2%U?E:66SJ1K34'[DJ<HUET
MY&URO;5JHE:UGJ]>7FO^>7_!3'X'>*_$]EX;^.GA[&IZ)X!\-S>&O&VDJS&]
MTC2;G7&U&R\5VD1&VYTR&ZU"6R\0JA6>RA73M1VRV<-X]MV7_!-;X'W?@GX>
M:M\9M;D9-4^+=G9VGAS3@NU;+P+HFHW<MKJ-P2<O=^)=6\R^A0 )#I%EIC_-
M)>3!/T0\4Z):^)O"_B;PU?0175EXC\.:[H-Y;2J&CGM]9TJ[TZ6)E8;2'6Y(
MR?NG#=1D>F?"[X3>$/"'PS^%7ANZUZWGF\-_"[0-(\1:;IWB#0K:?3]=T/PY
MI5O;V&G"=&@N&NIA):SH\BA;J*[N_/\ *5(W_'JG"N6X3C)\5S5:=2OA)\M*
MTZM.GF?N8:6*C:W(I9<E"-.HU!5W4G"24^6/Y+A/ CAZ'CKBO&6"JU,?B.'G
M"6%KUI2P^'XEJ3I9/5S?#I^]%U>&Z?L%AGSTZ6*E6QE-1=9QCR/TKW'X)6^;
MKQ+=GHEIIUHI &TM+<3S.I/4-B$' R&&<\K7AQYSQCJ, @XYQ]X<$_[0X)Y'
M&*^D?@O:)%X<U2[VX>[UDQAL'+16=G"JC/&0)9Y3@9 8GH:^LS.7+@ZBNUSR
MIP\]9IORVB_+:VFI^]X1-UXO^6,Y/R:C9?B[>GF>OT45SMSXO\)V=S-9W?B7
M0K:[M[K[%<6T^IVL<\%YFT7[+-&T@:*<M?V($;A6)O+; _?)GY>,)3;4(SG*
M*YFH1E)I7W?+&32;?E<]9N*^)Q2>GO-)/RNVD_3MKMJ=%5+4KX:7IFIZH2H&
MF:;J&H_-]W_0;*>Z&[D':6A4'!!P3@@\TMAJ.G:M;"]TN^M-1LS-<VXNK*>.
MYMS/9SO;74(EC+(9+:XCD@G4,3'*CHV&4BN4^)ES]C^&_P 0+O&?(\&>)&'U
M?2KF'/?IYF1[XITJ?-B*5%Q:<J].G.,HM-*=6E!JS2:^+7JK]&*4DH2FFK*G
M.2::M:,)O1K3[/F?EG!\>]5=5DG\): [RGSI7BOM8@8O(3))@?:9%!+,P!YQ
MG&#6U%^T+'%&6G\%.612VZS\77MOT!)(2;2;K'KC?C/4G@5\VQC:B#).%7K]
M!2NNY67^\-O_ 'U\O]:_9995E[_YAXJW\LJL=$K=*CZ)*UNK/A%C<5?^+=Z_
M%&#O??5POJ_.Y^C-S/<Q3D1W%]&IBM9EBEO)9)(?M-I!=&%Y%,:R-"9C%Y@C
M3>$#;%S@0&_O4P1?7HY XO+A>>V,2C)].]6-5&W4KM?[C11_016T,0'L $P!
MV  [5TG@W7/#^B2ZB^O:8=12X2S$(6RLK[?%!-))>Z:Z7SHMI#JL31PR:C;;
MKNS$6Z%26-?%3?)3<XT75FDFJ<.7GE>2V<HV=D];ZM*_=GT,=9\KJ>SC=IS;
ME963Z)]6M%;R5M#EUU340?DU/4!C^[J%T/Y3<5?T_6M5BOK%GU?53&M]:-(&
MU*\*F,3Q!P09BI&S(*D$$<'@UM>,=<\.ZW_9;>']*?14M+5;>\LQ:VR0W-P(
M+97U);N%S/++,\;0O;S@QQ1PQSPOON)D7B6)"D@X91N4^C+R#^!&:*:56FI2
MH^RE-23A.,'*#]Z*3:3B_LM--K5>82;A.T:CG&+34DW9K1MI-OST?W7/HM_@
MII+2RR/XCU5M\LCE4TVQ08=V<;2;E^!NP#C)X)JPGP6\-#)?5M?=O8Z?$N![
M?9YB/P.#C)'->L6TAFM;.<\&>RLIF&20&EM878 XSC<Q^E<?K7Q'\#^'KS5K
M#6?$5I97NAVNF7NK6IAO;B:SMM9F-OIDCI:VTQD^U3 *$A\R2$-&]PL*2QL_
MS<,7CZLG"G5KU)1T<:5-2:M)0NXPI-VNXKS<E:[NCU94<-!<TXTH)O>;LMN;
M>4U=VN[>3L<^GP<\*# :ZUQ_K>VJ GMG;9# SSU&,?EYIKNAIX&U+4[Y-*G>
MQEE;3/#DFL2-YDIDMFCU:[C%I)'(Q@BEV6=U((P!.C^4S-E/IFSN[:_M+6_L
MYEN+.]MH+RTN$#;)[:YB6:"9 RJVV2)U=0RJP! 90V17CWQ%\%>,_$_B!&L8
M+5M+L+*"&T-UJ-I:Q)+,HGO&"%WD+M(RJ[LF0$$8&U16F#QM6=>4,3B&J?+)
M3]O+D2Y6FXJRB^>4HJ+3U45))7T,ZU&"I\U*G[Z:Y732>LDUS.[:LDVTTGJU
M;N>,1>(9K.*6/2]-TG2I)HXXI+NVMYKB],4<@D")-?SW:1AF5?,:.%9& *[P
MI(K2T47GB.35QJ'B/5K1M-T2]UD>2C7*W,5@$\^#REN[-()&$J>4RJZL2P95
M"C=J:E\+_$6D:==:KJ5UHT%E91+-=-%=S7DL<;2)%D16]LS/AY$&%)."6Z U
MQZ6VD D3:W*/X2+32;J8NI^]EIKFR"JP(X8'G *GK7MJ5&M";P\TY72=2$)5
MG&7NNS<XR6L;JS:5F[6.%JK3E'VD6DD[0E)4TTTTG96O9V=[;K<ZGQSX0O\
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M!^5+UK,W"BBB@ HHHH **** "BBB@ HHHH **** $/ )]OY5\,_$W]AKP?\
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M'GIR^KXJC6?-)*ZYH2E3BXJ+;C*<?=U43Q,3B(<KIRC6IRERR3JT:E-63O\
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MQ)<Z?+<ZI)';,8[,W%XD47F7DC6NVSB>XV"OS!_9W\(RP_M"7/COP!\/];^
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M::=M4TU=.Y^,PG"HN:$HSC=KFA)25XMJ2O%M7BTTU>Z:::332****104444
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MU\T_L\_"3XD:UXCU;5K+P7KQL+'1=3TXW=WIT]A;S:A=7%O:-:6UU?"VA>>
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M\'ZA<K!;:/>:=H'B'Q:^C3OX*\)^)[>_T9]9_P!#(]#VK^(7XQ?"'3OVH?\
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MJ<B=KJ/,VU>RO9ZVU>][A2IT[^SIPA??DBHWM=J]DKV;=O7[BBBBL30****
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MMU8Q51N552C*+J3G5E)U(I2LJ<%[M*!^/?Q _:Z_;:\$Z3\2K#2/@/;7=O\
M"8_#ZTU'X@7G@?QYKMCKF@?&'Q!X8N?"GC+PYHEOKEEJ/BR?X2^ !XO7XU:7
M:7RS0>,TT659M(TLWMO+Z?\ '5_CE\6_V:/V8_B#_:'QB^#OQ4\2>/\ ]GFQ
M^(_A7X'>(O$FA?8O#GQ1^('@C0_BC_:UG<:+<:S#INB>%+O6-0L+W6[*VO\
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MWDAU6XM[O3#/TGB*U\=^&O'7Q)UCPOJOC+47CL?A9'X8T[Q!>^(O$'@FRO\
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H% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  1 !4# 2(  A$! Q$!_\0
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)0'HA1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
